Skip to main content
Top
Published in: Annals of Surgical Oncology 8/2015

01-08-2015 | Gynecologic Oncology

French Multicenter Study Evaluating the Risk of Lymph Node Metastases in Early-Stage Endometrial Cancer: Contribution of a Risk Scoring System

Authors: Sofiane Bendifallah, MD, Geoffroy Canlorbe, MD, Emmanuelle Arsène, MD, Pierre Collinet, MD, PhD, Florence Huguet, MD, PhD, Charles Coutant, MD, PhD, Delphine Hudry, MD, Olivier Graesslin, MD, PhD, Emilie Raimond, MD, Cyril Touboul, MD, PhD, Emile Daraï, MD, PhD, Marcos Ballester, MD, PhD

Published in: Annals of Surgical Oncology | Issue 8/2015

Login to get access

Abstract

Background

This study was designed to develop a risk scoring system (RSS) for predicting lymph node (LN) metastases in patients with early-stage endometrial cancer (EC).

Methods

Data of 457 patients with early-stage EC who received primary surgical treatment between January 2001 and December 2012 were abstracted from a prospective, multicentre database (training set). A risk model based on factors impacting LN metastases was developed. To assess the discrimination of the RSS, both internal by the bootstrap approach and external validation (validation set) were adopted.

Results

Overall the LN metastasis rate was 11.8 % (54/457). LN metastases were associated with five variables: age ≥60 years, histological grade 3 and/or type 2, primary tumor diameter ≥1.5 cm, depth of myometrial invasion ≥50 %, and the positive lymphovascular space involvement status. These variables were included in the RSS and assigned scores ranging from 0 to 9. The discrimination of the RSS was 0.81 [95 % confidence interval (CI) 0.78–0.84] in the training set. The area under the curve of the receiver-operating characteristics for predicting LN metastases after internal and external validation was 0.80 (95 % CI 0.77–0.83) and 0.85 (95 % CI 0.81–0.89), respectively. A total score of 6 points corresponded to the optimal threshold of the RSS with a rate of LN metastases of 7.5 % (29/385) and 34.7 % (25/72) for low-risk (≤6 points) and high-risk patients (>6 points), respectively. At this threshold, the diagnostic accuracy was 83 %.

Conclusions

This RSS could be useful in clinical practice to determine which patients with early-stage EC should benefit from secondary surgical staging including complete lymphadenectomy.
Literature
1.
2.
go back to reference Creasman WT, Odicino F, Maisonneuve P, et al. (2006) Carcinoma of the corpus uteri FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 95(1):S105–43.CrossRef Creasman WT, Odicino F, Maisonneuve P, et al. (2006) Carcinoma of the corpus uteri FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 95(1):S105–43.CrossRef
3.
go back to reference Benedetti Panici P, Basile S, Maneschi F, et al. (2008) Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 100:1707–16.PubMedCrossRef Benedetti Panici P, Basile S, Maneschi F, et al. (2008) Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 100:1707–16.PubMedCrossRef
4.
go back to reference Kitchener H, Swart AMC, Qian Q, Amos C, Parmar MKB. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373:125–36.CrossRef Kitchener H, Swart AMC, Qian Q, Amos C, Parmar MKB. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373:125–36.CrossRef
5.
go back to reference Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet. 2010;375:1165–72.PubMedCrossRef Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet. 2010;375:1165–72.PubMedCrossRef
6.
go back to reference Ballester M, Dubernard G, Lécuru F, et al. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol. 2011;12:469–76.PubMedCrossRef Ballester M, Dubernard G, Lécuru F, et al. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol. 2011;12:469–76.PubMedCrossRef
7.
go back to reference Colombo N, Preti E, Landoni F, et al. Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. (2013) 24:33–8.PubMed Colombo N, Preti E, Landoni F, et al. Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. (2013) 24:33–8.PubMed
8.
go back to reference Uccella S, Podratz KC, Aletti GD, Mariani A. Re: Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2009;101:897–8; author reply 898–9.PubMedCrossRef Uccella S, Podratz KC, Aletti GD, Mariani A. Re: Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2009;101:897–8; author reply 898–9.PubMedCrossRef
9.
go back to reference Kitchener HC. To stage or not to stage? That is the question: (with apologies to Shakespeare). Int J Gynecol Cancer. 2010;20:S55–6.PubMedCrossRef Kitchener HC. To stage or not to stage? That is the question: (with apologies to Shakespeare). Int J Gynecol Cancer. 2010;20:S55–6.PubMedCrossRef
10.
go back to reference Greer BE, Koh W-J, Abu-Rustum N, et al. Uterine Neoplasms. Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw. 2009;7:498–531. Greer BE, Koh W-J, Abu-Rustum N, et al. Uterine Neoplasms. Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw. 2009;7:498–531.
11.
go back to reference American College of Obstetricians and Gynecologists. ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol. 2005;106:413–25.CrossRef American College of Obstetricians and Gynecologists. ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol. 2005;106:413–25.CrossRef
12.
go back to reference Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma. Lancet. 2000;355:1404–11.PubMedCrossRef Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma. Lancet. 2000;355:1404–11.PubMedCrossRef
13.
go back to reference Nugent EK, Bishop EA, Mathews CA, et al. Do uterine risk factors or lymph node metastasis more significantly affect recurrence in patients with endometrioid adenocarcinoma? Gynecol Oncol. 2012;125:94–8.PubMedCrossRef Nugent EK, Bishop EA, Mathews CA, et al. Do uterine risk factors or lymph node metastasis more significantly affect recurrence in patients with endometrioid adenocarcinoma? Gynecol Oncol. 2012;125:94–8.PubMedCrossRef
14.
go back to reference Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004;92:744–51.PubMedCrossRef Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004;92:744–51.PubMedCrossRef
15.
go back to reference AlHilli MM, Podratz KC, Dowdy SC, et al. Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancer. Gynecol Oncol. 2013;128:294–9.PubMedCrossRef AlHilli MM, Podratz KC, Dowdy SC, et al. Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancer. Gynecol Oncol. 2013;128:294–9.PubMedCrossRef
16.
go back to reference Ballester M, Dubernard G, Bats A-S, et al. Comparison of diagnostic accuracy of frozen section with imprint cytology for intraoperative examination of sentinel lymph node in early-stage endometrial cancer: results of Senti-Endo study. Ann Surg Oncol. 2012;19:3515–21.PubMedCrossRef Ballester M, Dubernard G, Bats A-S, et al. Comparison of diagnostic accuracy of frozen section with imprint cytology for intraoperative examination of sentinel lymph node in early-stage endometrial cancer: results of Senti-Endo study. Ann Surg Oncol. 2012;19:3515–21.PubMedCrossRef
17.
go back to reference Frumovitz M, Slomovitz BM, Singh DK, et al. Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer. J Am Coll Surg. 2004;199:388–93.PubMedCrossRef Frumovitz M, Slomovitz BM, Singh DK, et al. Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer. J Am Coll Surg. 2004;199:388–93.PubMedCrossRef
18.
go back to reference Frumovitz M, Singh DK, Meyer L, et al. Predictors of final histology in patients with endometrial cancer. Gynecol Oncol. 2004;95:463–8.PubMedCrossRef Frumovitz M, Singh DK, Meyer L, et al. Predictors of final histology in patients with endometrial cancer. Gynecol Oncol. 2004;95:463–8.PubMedCrossRef
19.
go back to reference Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105:103–4.CrossRef Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105:103–4.CrossRef
20.
go back to reference Querleu D, Planchamp F, Narducci F, et al. Clinical practice guidelines for the management of patients with endometrial cancer in France: recommendations of the Institut National du Cancer and the Société Française d’Oncologie Gynécologique. Int J Gynecol Cancer. 2011;21:945–50.CrossRef Querleu D, Planchamp F, Narducci F, et al. Clinical practice guidelines for the management of patients with endometrial cancer in France: recommendations of the Institut National du Cancer and the Société Française d’Oncologie Gynécologique. Int J Gynecol Cancer. 2011;21:945–50.CrossRef
21.
go back to reference Delpech Y, Cortez A, Coutant C, et al. The sentinel node concept in endometrial cancer: histopathologic validation by serial section and immunohistochemistry. Ann Oncol. 2007;18:1799–803.CrossRef Delpech Y, Cortez A, Coutant C, et al. The sentinel node concept in endometrial cancer: histopathologic validation by serial section and immunohistochemistry. Ann Oncol. 2007;18:1799–803.CrossRef
22.
go back to reference Moses T, Holland PW. A comparison of statistical selection strategies for univariate and bivariate log-linear models. Br J Math Stat Psychol. 2010;63:557–74.PubMedCrossRef Moses T, Holland PW. A comparison of statistical selection strategies for univariate and bivariate log-linear models. Br J Math Stat Psychol. 2010;63:557–74.PubMedCrossRef
23.
go back to reference Steyerberg EW, Eijkemans MJ, Harrell FE Jr, Habbema JD. Prognostic modeling with logistic regression analysis: in search of a sensible strategy in small data sets. Med Decis Mak. 2001;21:45–56.CrossRef Steyerberg EW, Eijkemans MJ, Harrell FE Jr, Habbema JD. Prognostic modeling with logistic regression analysis: in search of a sensible strategy in small data sets. Med Decis Mak. 2001;21:45–56.CrossRef
24.
go back to reference Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361–87.PubMedCrossRef Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361–87.PubMedCrossRef
25.
go back to reference Harrell FE Jr, Lee KL, Pollock BG. Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst. 1988;80:1198–202.PubMedCrossRef Harrell FE Jr, Lee KL, Pollock BG. Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst. 1988;80:1198–202.PubMedCrossRef
26.
go back to reference Schisterman EF, Perkins NJ, Liu A, Bondell H. Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples. Epidemiol Camb Mass. 2005;16:73–81.PubMedCrossRef Schisterman EF, Perkins NJ, Liu A, Bondell H. Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples. Epidemiol Camb Mass. 2005;16:73–81.PubMedCrossRef
27.
go back to reference Miller ME, Hui SL, Tierney WM. Validation techniques for logistic regression models. Stat Med. 1991;10:1213–26.PubMedCrossRef Miller ME, Hui SL, Tierney WM. Validation techniques for logistic regression models. Stat Med. 1991;10:1213–26.PubMedCrossRef
28.
go back to reference Creasman WT, Mutch DE, Herzog TJ. ASTEC lymphadenectomy and radiation therapy studies: are conclusions valid? Gynecol Oncol. 2010;116:293–4.PubMedCrossRef Creasman WT, Mutch DE, Herzog TJ. ASTEC lymphadenectomy and radiation therapy studies: are conclusions valid? Gynecol Oncol. 2010;116:293–4.PubMedCrossRef
29.
go back to reference Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 1987;60:2035–41.PubMedCrossRef Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 1987;60:2035–41.PubMedCrossRef
30.
go back to reference Chi DS, Barakat RR, Palayekar MJ, et al. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. Int J Gynecol Cancer. 2008;18:269–73.CrossRef Chi DS, Barakat RR, Palayekar MJ, et al. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. Int J Gynecol Cancer. 2008;18:269–73.CrossRef
31.
go back to reference Briët JM, Hollema H, Reesink N, et al. Lymphvascular space involvement: an independent prognostic factor in endometrial cancer. Gynecol Oncol. 2005;96:799–804.PubMedCrossRef Briët JM, Hollema H, Reesink N, et al. Lymphvascular space involvement: an independent prognostic factor in endometrial cancer. Gynecol Oncol. 2005;96:799–804.PubMedCrossRef
32.
go back to reference Ballester M, Canlorbe G, Cortez A, et al. Histological and immunohistochemical profiles predict lymph node status in women with low-intermediate risk endometrial cancer. Gynecol Oncol. 2013;130:457–62.PubMedCrossRef Ballester M, Canlorbe G, Cortez A, et al. Histological and immunohistochemical profiles predict lymph node status in women with low-intermediate risk endometrial cancer. Gynecol Oncol. 2013;130:457–62.PubMedCrossRef
33.
go back to reference Greer BE, Koh W-J, Abu-Rustum N, et al. Uterine Neoplasms. Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw. 2009;7:498–531.PubMed Greer BE, Koh W-J, Abu-Rustum N, et al. Uterine Neoplasms. Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw. 2009;7:498–531.PubMed
34.
go back to reference Bendifallah S, Genin AS, Naoura I, et al. A nomogram for predicting lymph node metastasis of presumed stage I and II endometrial cancer. Am J Obstet Gynecol. 2012;207:197.e1–8.PubMed Bendifallah S, Genin AS, Naoura I, et al. A nomogram for predicting lymph node metastasis of presumed stage I and II endometrial cancer. Am J Obstet Gynecol. 2012;207:197.e1–8.PubMed
35.
go back to reference AlHilli MM, Podratz KC, Dowdy SC, et al. Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer. Gynecol Oncol 2013;131:103–8.PubMedCrossRef AlHilli MM, Podratz KC, Dowdy SC, et al. Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer. Gynecol Oncol 2013;131:103–8.PubMedCrossRef
36.
go back to reference Kamura T, Yahata H, Shigematsu T, et al. Predicting pelvic lymph node metastasis in endometrial carcinoma. Gynecol Oncol. 1999;72:387–91.PubMedCrossRef Kamura T, Yahata H, Shigematsu T, et al. Predicting pelvic lymph node metastasis in endometrial carcinoma. Gynecol Oncol. 1999;72:387–91.PubMedCrossRef
37.
go back to reference Luomaranta A, Leminen A, Loukovaara M. Prediction of lymph node and distant metastasis in patients with endometrial carcinoma: a new model based on demographics, biochemical factors, and tumor histology. Gynecol Oncol. 2013;129:28–32.PubMedCrossRef Luomaranta A, Leminen A, Loukovaara M. Prediction of lymph node and distant metastasis in patients with endometrial carcinoma: a new model based on demographics, biochemical factors, and tumor histology. Gynecol Oncol. 2013;129:28–32.PubMedCrossRef
38.
go back to reference Koskas M, Genin AS, Graesslin O, et al. Evaluation of a method of predicting lymph node metastasis in endometrial cancer based on five pre-operative characteristics. Eur J Obstet Gynecol Reprod Biol. 2014;172:115–9.PubMedCrossRef Koskas M, Genin AS, Graesslin O, et al. Evaluation of a method of predicting lymph node metastasis in endometrial cancer based on five pre-operative characteristics. Eur J Obstet Gynecol Reprod Biol. 2014;172:115–9.PubMedCrossRef
39.
go back to reference Kitajima K, Suzuki K, Senda M, et al. Preoperative nodal staging of uterine cancer: is contrast-enhanced PET/CT more accurate than non-enhanced PET/CT or enhanced CT alone? Ann Nucl Med. 2011;25:511–9.PubMedCrossRef Kitajima K, Suzuki K, Senda M, et al. Preoperative nodal staging of uterine cancer: is contrast-enhanced PET/CT more accurate than non-enhanced PET/CT or enhanced CT alone? Ann Nucl Med. 2011;25:511–9.PubMedCrossRef
40.
go back to reference Abu-Rustum NR, Khoury-Collado F, Pandit-Taskar N, et al. Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma? Gynecol Oncol. 2009;113:163–9.PubMedCentralPubMedCrossRef Abu-Rustum NR, Khoury-Collado F, Pandit-Taskar N, et al. Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma? Gynecol Oncol. 2009;113:163–9.PubMedCentralPubMedCrossRef
41.
go back to reference Yabushita H, Shimazu M, Yamada H, et al. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer. Gynecol Oncol. 2001;80:139–44.PubMedCrossRef Yabushita H, Shimazu M, Yamada H, et al. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer. Gynecol Oncol. 2001;80:139–44.PubMedCrossRef
42.
go back to reference Koh WJ, Greer BE, Abu-Rustum NR et al. National Comprehensive Cancer Network. Cervical cancer. J Natl Compr Canc Netw. 2013;11(3):320–43.PubMed Koh WJ, Greer BE, Abu-Rustum NR et al. National Comprehensive Cancer Network. Cervical cancer. J Natl Compr Canc Netw. 2013;11(3):320–43.PubMed
Metadata
Title
French Multicenter Study Evaluating the Risk of Lymph Node Metastases in Early-Stage Endometrial Cancer: Contribution of a Risk Scoring System
Authors
Sofiane Bendifallah, MD
Geoffroy Canlorbe, MD
Emmanuelle Arsène, MD
Pierre Collinet, MD, PhD
Florence Huguet, MD, PhD
Charles Coutant, MD, PhD
Delphine Hudry, MD
Olivier Graesslin, MD, PhD
Emilie Raimond, MD
Cyril Touboul, MD, PhD
Emile Daraï, MD, PhD
Marcos Ballester, MD, PhD
Publication date
01-08-2015
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 8/2015
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-4311-4

Other articles of this Issue 8/2015

Annals of Surgical Oncology 8/2015 Go to the issue